home / stock / ctyx / ctyx quote
Last: | $0.144 |
---|---|
Change Percent: | 15.2% |
Open: | $0.145 |
Close: | $0.144 |
High: | $0.1487 |
Low: | $0.125 |
Volume: | 3,508,421 |
Last Trade Date Time: | 04/28/2021 04:55:11 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.144 | $0.145 | $0.144 | $0.1487 | $0.125 | 3,508,421 | 04-28-2021 |
$0.125 | $0.1357 | $0.125 | $0.1357 | $0.12 | 1,148,595 | 04-27-2021 |
$0.1225 | $0.141 | $0.1225 | $0.1425 | $0.1132 | 2,319,443 | 04-26-2021 |
$0.138 | $0.155 | $0.138 | $0.155 | $0.1311 | 4,269,859 | 04-23-2021 |
$0.145 | $0.114 | $0.145 | $0.145 | $0.1125 | 3,586,440 | 04-22-2021 |
$0.1122 | $0.1036 | $0.1122 | $0.1139 | $0.095 | 1,563,409 | 04-21-2021 |
$0.1034 | $0.11 | $0.1034 | $0.1149 | $0.085 | 1,773,978 | 04-20-2021 |
$0.1147 | $0.118 | $0.1147 | $0.125 | $0.106 | 3,212,538 | 04-19-2021 |
$0.1215 | $0.145 | $0.1215 | $0.145 | $0.1151 | 3,617,198 | 04-16-2021 |
$0.145 | $0.1425 | $0.145 | $0.1501 | $0.138 | 613,561 | 04-15-2021 |
$0.15 | $0.1505 | $0.15 | $0.155 | $0.1424 | 645,860 | 04-14-2021 |
$0.1498 | $0.1624 | $0.1498 | $0.1624 | $0.144 | 1,008,801 | 04-13-2021 |
$0.1587 | $0.146 | $0.1587 | $0.185 | $0.1459 | 2,216,172 | 04-12-2021 |
$0.147 | $0.1615 | $0.147 | $0.163 | $0.1457 | 1,183,631 | 04-09-2021 |
$0.16 | $0.161 | $0.16 | $0.166 | $0.15 | 1,137,658 | 04-08-2021 |
$0.154 | $0.154 | $0.154 | $0.154 | $0.145 | 315,953 | 04-07-2021 |
$0.151 | $0.153 | $0.151 | $0.1545 | $0.1474 | 425,850 | 04-06-2021 |
$0.1516 | $0.16 | $0.1516 | $0.16 | $0.145 | 947,251 | 04-05-2021 |
$0.16 | $0.14915 | $0.16 | $0.16 | $0.141 | 905,721 | 04-02-2021 |
$0.16 | $0.14915 | $0.16 | $0.16 | $0.141 | 905,721 | 04-01-2021 |
News, Short Squeeze, Breakout and More Instantly...
Curative Biotechnology Inc Company Name:
CTYX Stock Symbol:
OTCMKTS Market:
Boca Raton, FL, May 25, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company targeting novel treatments for rare diseases, filed its Q1 quarterly report for the period...
Biotechnology Company Issues Highlights and Subsequent Events Boca Raton, Fla, March 09, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on ...
Connectyx Announces Key Biotech Industry Veterans to Management Team Expertise in Clinical Development, Regulatory Affairs and Manufacturing Represented PR Newswire BOCA RATON, Fla. , Feb. 11, 2021 /PRNewswire/ -- Connectyx Technologies Holdings Group, I...